Skip to main content
SpringerLink
Log in

Breast Cancer Prevention

  • Chapter
Fundamentals of Cancer Prevention

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • (1996). "Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer." Lancet 347(9017): 1713–1727.

    Google Scholar 

  • (2002). "Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial." Lancet 359(9324): 2131–2139.

    Google Scholar 

  • (2002). "Using Medication To Prevent Breast Cancer: Recommendations from the United States Preventive Services Task Force." Ann Intern Med 137(1): 162.

    Google Scholar 

  • ACS (2004). Breast Cancer Facts and Figures 2003–2004, American Cancer Society: http://www.cancer.org/downloads/STT/CAFF2003BrFPWSecured.pdf, accessed 11/20/04.

    Google Scholar 

  • Albert, K.S. and CM. Gernaat (1984). "Pharmacokinetics of ibuprofen." Am J Med 77(1 A): 40–46.

    PubMed  Google Scholar 

  • Amir, E., D.G. Evans, et al. (2003). "Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme." J Med Genet 40(11): 807–814.

    Article  PubMed  Google Scholar 

  • Anderson, G.L., M. Limacher, et al. (2004). "Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial." JAMA 291(14): 1701–1712.

    Article  PubMed  Google Scholar 

  • Antoine, C, F. Liebens, et al. (2004). "Influence of HRT on prognostic factors for breast cancer: a systematic review after the Women's Health Initiative trial." Hum Reprod 19(3): 741–756.

    Article  PubMed  Google Scholar 

  • Antoniou, A., P. D. Pharoah, et al. (2003). "Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies." Am J Hum Genet 72(5): 1117–1130.

    Article  PubMed  Google Scholar 

  • Bolan, P.J., S. Meisamy, et al. (2003). "In vivo quantification of choline compounds in the breast with 1H MR spectroscopy." Magn Reson Med 50(6): 1134–1143.

    Article  PubMed  Google Scholar 

  • Boland, G.P., W.F. Knox, et al. (2002). "Molecular markers and therapeutic targets in ductal carcinoma in situ." Microsc Res Tech 59(1): 3–11.

    Article  PubMed  Google Scholar 

  • Boyd, N.F., G.A. Lockwood, et al. (1998). "Mammographic densities and breast cancer risk." Cancer Epidemiol Biomarkers Prev 7(12): 1133–1144.

    PubMed  Google Scholar 

  • Boyd, N.F., L.J. Martin, et al. (2001). "Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention." Curr Oncol Rep 3(4): 314–321.

    PubMed  Google Scholar 

  • Buist, D.S.M., P.L. Porter, et al. (2004). "Factors Contributing to Mammography Failure in Women Aged 40–49 Years." J Natl Cancer Inst 96(19): 1432–1440.

    PubMed  Google Scholar 

  • Byers, T., M. Nestle, et al. (2002). "American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer with Healthy Food Choices and Physical Activity." CA Cancer J Clin 52(2): 92–119.

    PubMed  Google Scholar 

  • Calderon-Margalit, R. and O. Paltiel (2004). "Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature." IntJCancer 112(3): 357–364.

    Google Scholar 

  • Calle, E. E., H. Frumkin, et al. (2002). "Organochlorines and Breast Cancer Risk." CA Cancer J Clin 52(5): 301–309.

    PubMed  Google Scholar 

  • Carmichael, A., A.S. Sami, et al. (2003). "Breast cancer risk among the survivors of atomic bomb and patients exposed to therapeutic ionising radiation." European Journal of Surgical Oncology 29(5): 475–479.

    Article  PubMed  Google Scholar 

  • Cauley, J.A., L. Norton, et al. (2001). "Continued breast cancer risk reduction in postmeno-pausal women treated with raloxifene: 4-year results from the MORE trial. Multiple out-comes of raloxifene evaluation." Breast Cancer Res Treat 65(2): 125–134.

    Article  PubMed  Google Scholar 

  • Cerhan, J.R., J.D. Potter, et al. (2004). "Adherence to the AICR Cancer Prevention Recommendations and Subsequent Morbidity and Mortality in the Iowa Women's Health Study Cohort." Cancer Epidemiol Biomarkers Prev 13(7): 1114–1120.

    PubMed  Google Scholar 

  • Chlebowski, R.T., M. Pettinger, et al. (2004). "Insulin, Physical Activity, and Caloric Intake in Postmenopausal Women: Breast Cancer Implications." J Clin Oncol 22(22): 4507–4513.

    Article  PubMed  Google Scholar 

  • Claus, E.B., N. Risch, et al. (1991). "Genetic analysis of breast cancer in the cancer and steroid hormone study." Am J Hum Genet 48(2): 232–242.

    PubMed  Google Scholar 

  • Claus, E. B., M. Stowe, et al. (2003). "The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry." The Breast 12(6): 451–456.

    Article  PubMed  Google Scholar 

  • Clemons, M., L. Loijens, et al. (2000). "Breast cancer risk following irradiation for Hodgkin's disease." Cancer Treatment Reviews 26(4): 291–302.

    Article  PubMed  Google Scholar 

  • Colditz, G.A. and B. Rosner (2000). "Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study." Am J Epidemiol 152(10): 950–964.

    Article  PubMed  Google Scholar 

  • Costa, A., F. Formelli, et al. (1994). "Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide." Cancer Res 54(7 Suppl): 2032s–2037s.

    PubMed  Google Scholar 

  • Coyle, Y. M. (2004). "The effect of environment on breast cancer risk." Breast Cancer Res Treat 84(3): 273–288.

    Article  PubMed  Google Scholar 

  • Davies, G.L. (2003). "Cyclooxygenase-2 and chemoprevention of breast cancer." J Steroid Biochem Mol Biol 86(3–5): 495–499.

    Article  PubMed  Google Scholar 

  • Decensi, A., D. Serrano, et al. (2003). "Breast cancer prevention trials using retinoids." J Mammary Gland Biol Neoplasia 8(1): 19–30.

    Article  PubMed  Google Scholar 

  • Deligeoroglou, E., E. Michailidis, et al. (2003). "Oral Contraceptives and Reproductive System Cancer." Ann NY Acad Sci 997(1): 199–208.

    Article  PubMed  Google Scholar 

  • Dupont, W. D. and D.L. Page (1985). "Risk factors for breast cancer in women with proliferative breast disease." N Engl J Med 312(3): 146–151.

    PubMed  Google Scholar 

  • Dupont, W.D., D.L. Page, et al. (1994). "Long-Term Risk of Breast Cancer in Women with Fibroadenoma." N Engl J Med 331(1): 10–15.

    Article  PubMed  Google Scholar 

  • Erbas, B., A. Amos, et al. (2004). "Incidence of Invasive Breast Cancer and Ductal Carcinoma In situ in a Screening Program by Age: Should Older Women Continue Screening?" Cancer Epidemiol Biomarkers Prev 13(10): 1569–1573.

    PubMed  Google Scholar 

  • Ernster, V. L., J. Barclay, et al. (1996). "Incidence of and treatment for ductal carcinoma in situ of the breast." JAMA 275(12): 913–918.

    Article  PubMed  Google Scholar 

  • Fisher, B., J.P. Costantino, et al. (1998). "Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study." J Natl Cancer Inst 90(18): 1371–1388.

    Article  PubMed  Google Scholar 

  • Fournier, A., F. Berrino, et al. (2004). "Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort." Int J Cancer 114(3):448–454.

    Article  Google Scholar 

  • Gail, M.H., L.A. Brinton, et al. (1989). "Projecting individualized probabilities of developing breast cancer for white females who are being examined annually." J Natl Cancer Inst 81(24): 1879–1886.

    PubMed  Google Scholar 

  • Gail, M.H., J.P. Costantino, et al. (1999). "Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer." J Natl Cancer Inst 91(21): 1829–1846.

    Article  PubMed  Google Scholar 

  • Gammon, M. D., S.M. Eng, et al. (2004). "Environmental tobacco smoke and breast cancer incidence." Environmental Research 96(2): 176–185.

    Article  PubMed  Google Scholar 

  • Garbe, E., L. Levesque, et al. (2004). "Variability of breast cancer risk in observational studies of hormone replacement therapy: a meta-regression analysis." Maturitas 47(3): 175–183.

    Article  PubMed  Google Scholar 

  • Garfinkel, L, C. C. Boring, et al. (1994). "Changing trends. An overview of breast cancer incidence and mortality." Cancer 74(1 Suppl): 222–227.

    PubMed  Google Scholar 

  • Ghafoor, A., A. Jemal, et al. (2003). "Trends in Breast Cancer by Race and Ethnicity." CA Cancer J Clin 53(6): 342–355.

    PubMed  Google Scholar 

  • Giordano, S.H., A.U. Buzdar, et al. (2002). "Breast Cancer in Men." Ann Intern Med 137(8): 678–687.

    PubMed  Google Scholar 

  • Goss, P. E. and K. Strasser-Weippl (2004). "Prevention Strategies with Aromatase Inhibitors." Clin Cancer Res 10(1): 372–379.

    Article  Google Scholar 

  • Haffty, B.G., C. Lee, et al. (1998). "Prognostic significance of mammographic detection in a cohort of conservatively treated breast cancer patients." Cancer J Sci Am 4(1): 35–40.

    PubMed  Google Scholar 

  • Hankinson, S. E., W.C. Willett, et al. (1998). "Circulating concentrations of insulin-like growth factor I and risk of breast cancer." Lancet 351(9113): 1393–1396.

    Article  PubMed  Google Scholar 

  • Harris, R.E., R.T. Chlebowski, et al. (2003). "Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative." Cancer Res 63(18): 6096–6101.

    PubMed  Google Scholar 

  • Hartmann, L.C., D.J. Schaid, et al. (1999). "Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer." N Engl J Med 340(2): 77–84.

    Article  PubMed  Google Scholar 

  • Hemminki, K., R. Rawal, et al. (2004). "Mammographic Screening Is Dramatically Changing Age-Incidence Data for Breast Cancer." J Clin Oncol 22(22): 4652–4653.

    Article  PubMed  Google Scholar 

  • Henderson, B.E. and L. Bernstein (1991). "The international variation in breast cancer rates: an epidemiological assessment." Breast Cancer Res Treat 18(Suppl 1): S11–17.

    Article  PubMed  Google Scholar 

  • Hodgson, S.V., P.J. Morrison, et al. (2004). "Breast cancer genetics: unsolved questions and open perspectives in an expanding clinical practice." Am J Med Genet 129C(1): 56–64.

    Article  Google Scholar 

  • Hollingsworth, A.B., S.E. Singletary, et al. (2004). "Current comprehensive assessment and management of women at increased risk for breast cancer." The American Journal of Surgery 187(3): 349–362.

    Article  Google Scholar 

  • Holmes, M.D. and W.C. Willett (2004). "Does diet affect breast cancer risk?" Breast Cancer Res 6(4): 170–178.

    Article  PubMed  Google Scholar 

  • Humphrey, L.L., M. Helfand, et al. (2002). "Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force." Ann Intern Med 137(5 Part 1): 347–360.

    PubMed  Google Scholar 

  • Jemal, A., R.C. Tiwari, et al. (2004). "Cancer statistics, 2004." CA Cancer J Clin 54(1): 8–29.

    PubMed  Google Scholar 

  • Jernstrom, H., C. Lerman, et al. (1999). "Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2." The Lancet 354(9193): 1846–1850.

    Article  Google Scholar 

  • Johnson, T.W., K. E. Anderson, et al. (2002). "Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer." Cancer Epidemiol Biomarkers Prev 11(12): 1586–1591.

    PubMed  Google Scholar 

  • Kaaks, R. (1996). "Nutrition, hormones, and breast cancer: is insulin the missing link?" Cancer Causes Control 7(6): 605–625.

    Article  PubMed  Google Scholar 

  • Kelsey, J.L. and L. Bernstein (1996). "Epidemiology and prevention of breast cancer." Annu Rev Public Health 17: 47–67.

    Article  PubMed  Google Scholar 

  • Key, T.J., A. Schatzkin, et al. (2004). "Diet, nutrition and the prevention of cancer." Public Health Nutr 7(1 A): 187–200.

    Article  PubMed  Google Scholar 

  • Kollias, J., I.O. Ellis, et al. (1999). "Clinical and histological predictors of contralateral breast cancer." Eur J Surg Oncol 25(6): 584–589.

    Article  PubMed  Google Scholar 

  • Lacroix, M., R.A. Toillon, et al. (2004). "Stable ‘portrait’ of breast tumors during progression: data from biology, pathology and genetics." Endocr Relat Cancer 11(3): 497–522.

    Article  PubMed  Google Scholar 

  • Laden, F. and D.J. Hunter (1998). "Environmental risk factors and female breast cancer." Annu Rev Public Health 19: 101–123.

    Article  PubMed  Google Scholar 

  • Law, M. (2000). "Dietary fat and adult diseases and the implications for childhood nutrition: an epidemiologic approach." Am J Clin Nutr 72(5): 1291–1296.

    Google Scholar 

  • Li, C.I., B.O. Anderson, et al. (2002). "Changing incidence of lobular carcinoma in situ of the breast." Breast Cancer Res Treat 75(3): 259–268.

    Article  PubMed  Google Scholar 

  • Lo, S.S. and V.G. Vogel (2004). "Endocrine prevention of breast cancer using selective oestrogen receptor modulators (SORMs)." Best Practice & Research Clinical Endocrinology & Metabolism 18(1): 97–111.

    Google Scholar 

  • Louie, A.Y., M.M. Huber, et al. (2000). "In vivo visualization of gene expression using magnetic resonance imaging." Not Biotechnol 18(3): 321–325.

    Article  Google Scholar 

  • Moorman, P.G., J.M. Grubber, et al. (2003). "Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast." Cancer Causes Control 14(10): 915–922.

    Article  PubMed  Google Scholar 

  • Morris, E.A., L. Liberman, et al. (2003). "MRI of occult breast carcinoma in a high-risk population." Am J Roentgenol 181(3): 619–626.

    Google Scholar 

  • Narod, S.A. and W.D. Foulkes (2004). "BRCA1 and BRCA2: 1994 and beyond." Nature Reviews Cancer 4(9): 665–676.

    Article  PubMed  Google Scholar 

  • Nayfield, S.G., J.E. Karp, et al. (1991). "Potential role of tamoxifen in prevention of breast cancer." J Natl Cancer Inst 83(20): 1450–1459.

    PubMed  Google Scholar 

  • Nelson, H.D., L.L. Humphrey, et al. (2002). "Postmenopausal hormone replacement therapy: scientific review." JAMA 288(7): 872–881.

    Article  PubMed  Google Scholar 

  • Olsen, J.H., N. Seersholm, et al. (1999). "Cancer risk in close relatives of women with early-onset breast cancer — a population-based incidence study." Br J Cancer 79(3–4): 673–679.

    Article  PubMed  Google Scholar 

  • Page, D.L. (2004). "Breast lesions, pathology and cancer risk." Breast J 10(Suppl 1): S3–4.

    Article  Google Scholar 

  • Page, D.L. and R.A. Jensen (1994). "Evaluation and management of high risk and premalignant lesions of the breast." World J Surg 18(1): 32–38.

    Article  PubMed  Google Scholar 

  • Parker, E. D. and A.R. Folsom (2003). "Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study." Int J Obes Relat Metab Disord 27(12): 1447–1452.

    Article  PubMed  Google Scholar 

  • Parkin, D.M. (2004). "International variation." Oncogene 23(38): 6329–6340.

    Article  PubMed  Google Scholar 

  • Pike, M.C., C.L. Pearce, et al. (2004). "Prevention of cancers of the breast, endometrium and ovary." Oncogene 23(38): 6379–6391.

    Article  PubMed  Google Scholar 

  • Powles, T., R. Eeles, et al. (1998). "Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial." Lancet 352(9122): 98–101.

    PubMed  Google Scholar 

  • Radimer, K. L., R. Ballard-Barbash, et al. (2004). "Weight change and the risk of late-onset breast cancer in the original Framingham cohort." Nutr Cancer 49(1): 7–13.

    Article  PubMed  Google Scholar 

  • Rebbeck, T.R., A.M. Levin, et al. (1999). "Breast cancer risk after bilateral prophylactic oo-phorectomy in BRCA1 mutation carriers." J Natl Cancer Inst 91(17): 1475–1479.

    Article  PubMed  Google Scholar 

  • Ries, L.A.G., M.P. Eisner, et al. (2004). SEER Cancer Statistics Review, 1995 2001. Bethesda, MD, National Cancer Institute.

    Google Scholar 

  • Rockhill, B., D. Spiegelman, et al. (2001). "Validation of the Gail et al. Model of Breast Cancer Risk Prediction and Implications for Chemoprevention." J Natl Cancer Inst 93(5): 358–366.

    Article  PubMed  Google Scholar 

  • Rossouw, J. E., G. L. Anderson, et al. (2002). "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial." JAMA 288(3): 321–333.

    Article  PubMed  Google Scholar 

  • Ruffin, M.T.T., D.A. August, et al. (1993). "Selection criteria for breast cancer chemoprevention subjects." J Cell Biochem Suppl 17G: 234–241.

    Article  PubMed  Google Scholar 

  • Sakorafas, G.H., E. Krespis, et al. (2002). "Risk estimation for breast cancer development; a clinical perspective." Surg Oncol 10(4): 183–192.

    Article  PubMed  Google Scholar 

  • Serrano, D., E. Perego, et al. (2004). "Progress in chemoprevention of breast cancer." Critical Reviews in Oncology/Hematology 49(2): 109–117.

    Article  PubMed  Google Scholar 

  • Shen, Q. and P.H. Brown (2003). "Novel agents for the prevention of breast cancer: targeting transcription factors and signal transduction pathways." J Mammary Gland Biol Neoplasia 8(1): 45–73.

    Article  PubMed  Google Scholar 

  • Shi, R., H. Yu, et al. (2004). "IGF-I and breast cancer: a meta-analysis." Int J Cancer 111(3): 418–423.

    Article  PubMed  Google Scholar 

  • Smith, R.A. (2000). "Breast cancer screening among women younger than age 50: a current assessment of the issues." CA Cancer J Clin 50(5): 312–336.

    PubMed  Google Scholar 

  • Smith, R.A., D. Saslow, et al. (2003). "American Cancer Society guidelines for breast cancer screening: update 2003." CA Cancer J Clin 53(3): 141–169.

    PubMed  Google Scholar 

  • Stankovic, T, A.M. Kidd, et al. (1998). "ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer." Am J Hum Genet 62(2): 334–345.

    Article  PubMed  Google Scholar 

  • Stoll, B.A. (1998). "Western diet, early puberty, and breast cancer risk." Breast Cancer Res Treat 49(3): 187–193.

    Article  PubMed  Google Scholar 

  • Stoll, B.A. (1999). "Western nutrition and the insulin resistance syndrome: a link to breast cancer." Eur J Clin Nutr 53(2): 83–87.

    Article  PubMed  Google Scholar 

  • Sugumar, A., Y.C. Liu, et al. (2004). "Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature." Int J Cancer 111(2): 293–297.

    Article  PubMed  Google Scholar 

  • Terry, M.B., M. D. Gammon, et al. (2004). "Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk." JAMA 291(20): 2433–2440.

    Article  PubMed  Google Scholar 

  • The Women's Health Initiative Steering Committee (2004). "Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial." JAMA 291(14): 1701–1712.

    Google Scholar 

  • Thomas, D.B., D.L. Gao, et al. (1997). "Randomized trial of breast self-examination in Shanghai: methodology and preliminary results." J Natl Cancer Inst 89(5): 355–365.

    Article  PubMed  Google Scholar 

  • Tobias, J.S. (2004). "Recent advances in endocrine therapy for postmenopausal women with early breast cancer: implications for treatment and prevention." Ann Oncol 15(12): 1738–1747.

    Article  PubMed  Google Scholar 

  • Toniolo, P., P. F. Bruning, et al. (2000). "Serum insulin-like growth factor-l and breast cancer." Int J Cancer 88(5): 828–832.

    Article  PubMed  Google Scholar 

  • Tryggvadottir, L, E.J. Olafsdottir, et al. (2003). "BRCA2 mutation carriers, reproductive factors and breast cancer risk." Breast Cancer Res 5(5): R121–128.

    Article  PubMed  Google Scholar 

  • Tyrer, J., S.W. Duffy, et al. (2004). "A breast cancer prediction model incorporating familial and personal risk factors." Stat Med 23(7): 1111–1130.

    Article  PubMed  Google Scholar 

  • Vogel, V.G. (1991). "High-risk populations as targets for breast cancer prevention trials." Preventive Medicine 20(1): 86–100.

    Article  PubMed  Google Scholar 

  • Vogel, V.G. (2004). "Atypia in the assessment of breast cancer risk: implications for management." Diagn Cytopathol 30(3): 151–157.

    Article  PubMed  Google Scholar 

  • Ward, E., A. Jemal, et al. (2004). "Cancer disparities by race/ethnicity and socioeconomic status." CA Cancer J Clin 54(2): 78–93.

    PubMed  Google Scholar 

  • Warren Burhenne, L.J., S.A. Wood, et al. (2000). "Potential contribution of computer-aided detection to the sensitivity of screening mammography." Radiology 215(2): 554–562.

    PubMed  Google Scholar 

  • Warren, R. (2004). "Hormones and mammographic breast density." Maturitas 49(1): 67–78.

    Article  PubMed  Google Scholar 

  • Weissleder, R., A. Moore, et al. (2000). "In vivo magnetic resonance imaging of transgene expression." Nat Med 6(3): 351–355.

    Article  PubMed  Google Scholar 

  • White, S., R. Taetle, et al. (1990). "Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects." Cancer Res 50(19): 6295–6301.

    PubMed  Google Scholar 

  • Wu, K., H.-T. Kim, et al. (2002). "Suppression of Mammary Tumorigenesis in Transgenic Mice by the RXR-selective Retinoid, LGD1069." Cancer Epidemiol Biomarkers Prev 11(5): 467–474.

    PubMed  Google Scholar 

  • Yang, L.M., U.C. Tin, et al. (1999). "Role of retinoid receptors in the prevention and treatment of breast cancer." J Mammary Gland Biol Neoplasia 4(4): 377–388

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Medicine, University of Arizona, Tucson, AZ, 85724

    Patricia A. Thompson, Ana Maria Lopez & Alison Stopeck

Authors
  1. Patricia A. Thompson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana Maria Lopez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alison Stopeck
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cancer Prevention and Control, Arizona Cancer Center, 1515 N. Campbell Avenue, PO Box 245024, Tuscon, AZ, 85724

    David S. Alberts  & Lisa M. Hess  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Thompson, P.A., Lopez, A.M., Stopeck, A. (2005). Breast Cancer Prevention. In: Alberts, D.S., Hess, L.M. (eds) Fundamentals of Cancer Prevention. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26337-3_12

Download citation

  • DOI: https://doi.org/10.1007/3-540-26337-3_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-24212-3

  • Online ISBN: 978-3-540-26337-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation